| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 06/08/2006 | US20060121010 Chorionic gonadotropin DNA vaccines and methods |
| 06/08/2006 | US20060121009 Apparatus and method for machining michrochamber for cell culture |
| 06/08/2006 | US20060121008 Primarily cultured adipocytes for gene therapy |
| 06/08/2006 | US20060121002 Methods and compositions for tissue regeneration |
| 06/08/2006 | US20060121000 Methods and vectors for controlling gene expression |
| 06/08/2006 | US20060120999 Protein and peptide expression for passive immunity |
| 06/08/2006 | US20060120995 Neoadjuvant genetic compositions and methods |
| 06/08/2006 | US20060120992 Rapid dehydration of proteins |
| 06/08/2006 | US20060120971 Agents and methods for administration to the central nervous system |
| 06/08/2006 | CA2589644A1 Mda-7 protein variants having antiproliferative activity |
| 06/08/2006 | CA2588868A1 Remedy for alzheimer's disease |
| 06/08/2006 | CA2587493A1 Bacterial packaging strains usefuel for generation and production of recombinant double-stranded rna nucleocapsids and uses thereof |
| 06/07/2006 | EP1666489A1 DNA encoding an antigenic protein of eimeria apical membrane antigen 1 and use thereof |
| 06/07/2006 | EP1666058A2 Method of and compositions for immunization with the pseudomonas V antigen |
| 06/07/2006 | EP1664316A1 Polyethyleneglycol-modified lipid compounds and uses thereof |
| 06/07/2006 | EP1664315A1 Aav vectors for in vivo gene therapy of rheumatoid arthritis |
| 06/07/2006 | EP1664314A2 Improved adeno-associated virus (aav) vector for gene therapy |
| 06/07/2006 | EP1664277A2 Method of preparation of pharmaceutically grade plasmid dna |
| 06/07/2006 | EP1664267A2 Modulation of growth hormone receptor expression and insulin-like growth factor expression |
| 06/07/2006 | EP1664124A2 Product comprising a c4bp core protein and a monomeric antigen, and its use |
| 06/07/2006 | EP1664075A2 Methods for diagnosing and treatment of conditions that alter phosphate transport in mammals |
| 06/07/2006 | EP1663317A1 Epas1 gene transfer to improve cell therapy |
| 06/07/2006 | EP1663316A2 Nucleic acid lipophilic conjugates |
| 06/07/2006 | EP1663315A2 Targeted lipid-drug formulations for delivery of drugs to myeloid and lymphoid immune cells |
| 06/07/2006 | EP1663300A1 Inhibitors of pace4 for the treatment of arthritis |
| 06/07/2006 | EP1409673B1 Human leucine-rich repeat containing protein, expressed predominantely in small intestine, hlrrsi1 |
| 06/07/2006 | EP1140965B1 Antibacterial protonated oligonucleotides |
| 06/07/2006 | EP1002081B1 Delayed progression to aids by a missense allele of the ccr2 gene |
| 06/07/2006 | EP0972015B1 Enzyme having s-adenosyl-l-homocysteine hydrolase (ahcy) type activity |
| 06/07/2006 | EP0871735B1 Therapeutic compositions for the treatment of Lawsonia intracellularis infections |
| 06/07/2006 | EP0813606B1 Method of purification of recombinant viral vectors containing a therapeutic gene |
| 06/07/2006 | EP0813538B1 Compositions and methods for the treatment and diagnosis of immune disorders |
| 06/07/2006 | EP0772437B1 Compositions for delivery of genetic material |
| 06/07/2006 | CN1784426A Antibody targeted at antigen specific to cancer |
| 06/07/2006 | CN1784421A Immunogenic human TNF alpha analogues with reduced cytotoxicity and methods of their preparation |
| 06/07/2006 | CN1784248A Needleless syringe having medical agent accommodated therein |
| 06/07/2006 | CN1782086A Adeno-associated virus mediating trigenic cell expression system |
| 06/07/2006 | CN1782085A Human growth colyone receptor 2 subtgpe and E.coli cytosine deaminizing enzyme co-expression vector and its establishing and use |
| 06/07/2006 | CN1782072A Vector |
| 06/07/2006 | CN1782071A Recombinant mva virus and the use thereof |
| 06/07/2006 | CN1781934A HER-2 analogue antigen epitope and peptide containing said epitope |
| 06/07/2006 | CN1781553A Subunit vaccine of H5N1 subtype bird flu virus gene ergineering and its preparing method |
| 06/07/2006 | CN1781551A Fumor invasion and metastasis resisting function and use of venin cysteine proteinase inhibitor |
| 06/07/2006 | CN1781549A Adeno-associated virus vector preparation and medicinal composition containing it and its use |
| 06/07/2006 | CN1258596C Leporipox-based vector vaccines |
| 06/07/2006 | CN1258589C Method of isolating bi-potent hepatic progenitor cells |
| 06/07/2006 | CN1258563C Highly-neutralized ethylene copolymers and their use in golf balls |
| 06/07/2006 | CN1258358C Polymeric micelle composition |
| 06/06/2006 | US7057013 TGFβ1 inhibitor peptides |
| 06/06/2006 | US7056901 Microgel particles for the delivery of bioactive materials |
| 06/06/2006 | US7056897 Inducible expression vectors and methods of use thereof |
| 06/06/2006 | US7056896 Carbohydrate or 2′-modified oligonucleotides having alternating internucleoside linkages |
| 06/06/2006 | US7056887 Treatment of acute coronary syndrome with GLP-1 |
| 06/06/2006 | US7056885 Fibroblast growth factor and nucleic acids encoding same |
| 06/06/2006 | US7056741 Surface transfection and expression procedure |
| 06/06/2006 | US7056730 Expression of heterologous genes from an IRES translational cassette in retroviral vectors |
| 06/06/2006 | US7056729 Botulinum neurotoxin-substance P conjugate or fusion protein for treating pain |
| 06/06/2006 | US7056720 LLG polypeptides of the triacylglycerol lipase family, and compositions and methods for their use in enzymatic hydrolysis, and protein and gene therapies |
| 06/06/2006 | US7056704 RNA interference mediating small RNA molecules |
| 06/06/2006 | US7056701 Hormone and albumin fusion protein |
| 06/06/2006 | US7056699 Vector capable of transduction non-dividing or slowly diviving cell; gene expression in protein; genetic engineering |
| 06/06/2006 | US7056696 Expression vector containing a drug-resistance gene having a destabilizing sequence as selection marker |
| 06/06/2006 | US7056513 Peptides for use in the treatment of cancer and aging |
| 06/06/2006 | US7056512 controlling and increasing muscle growth, especially in farm animals for slaughter, by administering an immunogenically effective amount ofa modified GDF-8 polypeptide |
| 06/06/2006 | US7056510 Streptococcus pneumoniae SP036 polynucleotides, polypeptides, antigens and vaccines |
| 06/06/2006 | US7056503 Antigrowth agents; solid support releasing protein |
| 06/06/2006 | US7056502 Recombinant aav vectors with AAV5 capsids and AAV5 vectors pseudotyped in heterologous capsids |
| 06/06/2006 | US7056501 used to develop diagnostic assays for the detection of Neospora infections in cattle and other animals |
| 06/06/2006 | CA2071214C Method of delivering molecules into eukaryotic cells |
| 06/01/2006 | WO2006058048A2 Method of determining a cellular response to a biological agent |
| 06/01/2006 | WO2006058038A2 In vitro and in vivo silencing of human c-myc oncogene expression by poly-dnp-rna |
| 06/01/2006 | WO2006057389A1 Novel transcriptional factor phosphorylated by amp protein kinase and gene thereof |
| 06/01/2006 | WO2006057289A1 Novel shuttle vector |
| 06/01/2006 | WO2006057278A1 Remedy for heart disease using map kinase tnni3k |
| 06/01/2006 | WO2006056885A2 Igf-1 isoforms |
| 06/01/2006 | WO2006056054A1 Treatment of cancer with a combination of an agent that perturbs the egf signaling pathway and an oligonucleotide that reduces clusterin levels |
| 06/01/2006 | WO2006035432A3 Gene silencing for use in dermatology |
| 06/01/2006 | WO2006032041A3 Compositions and methods for inhibiting expression of anti-apoptotic genes |
| 06/01/2006 | WO2006031467A9 Isolated lineage negative hematopoietic stem cells and methods of treatment therewith |
| 06/01/2006 | WO2006013103A3 Inducible gene expression |
| 06/01/2006 | WO2005117975A3 Methods for treating vascular disease |
| 06/01/2006 | WO2005103692A3 Methods, compositions and compound assays for inhibiting amyloid-beta protein production |
| 06/01/2006 | WO2005076786A3 Colon carcinoma related oligonucleotides and methods of use |
| 06/01/2006 | US20060116627 Compositions, kits, methods, and apparatus for transvascular delivery of a composition to an extravascular tissue of a mammal |
| 06/01/2006 | US20060116508 Novel 27411, 23413, 22438, 23553, 25278, 26212, NARC SC1, NARC 10A, NARC 1, NARC 12, NARC 13, NARC17, NARC 25, NARC 3, NARC 4, NARC 7, NARC 8, NARC 11, NARC 14A, NARC 15, NARC 16, NARC 19, NARC 20, NARC 26, NARC 27, NARC 28, NARC 30, NARC 5, NARC 6, NARC 9, NARC 10C, NARC 8B, NARC 9, NARC2A, NARC 16B, NARC 1C, NARC 1A, NARC 25, 86604 and 32222 molecules and uses therefor |
| 06/01/2006 | US20060116344 Remedy and preventive for diseases caused by NF-kB |
| 06/01/2006 | US20060116343 Sphingosine kinase-1 mediates gene expression regulation of a monocyte chemoattractant protein-1 gene |
| 06/01/2006 | US20060116342 Protective immunity or immunological tolerance induced with RNA, particularly total cellular RNA |
| 06/01/2006 | US20060116341 Pharmaceutical composition for treating and/or preventing a pathology associated with an obsessional behavior or with obesity |
| 06/01/2006 | US20060116340 Herpesvirus ribozymes and vectors |
| 06/01/2006 | US20060116339 Antisense modulation of purinoreceptor p2x3 |
| 06/01/2006 | US20060116338 Therapeutic and diagnostic tools for proliferative and developmental disorders and as vehicles for identifying region q26.2 on a mammalian chromosome 3; gene therapy; detecting Cornelia de Lange syndrome; diagnosing neoplasia; inducing a cell to change its pattern of differentiation |
| 06/01/2006 | US20060116323 Tumor-inhibiting protein and the use thereof |
| 06/01/2006 | US20060116319 Method for identifying and treating photodamaged skin |
| 06/01/2006 | US20060115852 proteins or polypeptides comprising amino acid sequences, used for diagnosis and therapy of diseases associated with oncogenes, such as transcription and apoptosis |
| 06/01/2006 | US20060115829 An isolated nucleic acid sequence encoding a DNA methyltransferase-3B variant having aseleted amino acid sequence; screening for enzyme inhibitor compounds to be used as anticarcinogenic agents for, particularly, lung cancer and, more particularly, non-small cell lung cancer |
| 06/01/2006 | US20060115537 First nanoparticle of poly-gamma -glutamic acid/polylactide block copolymer and ganciclovir conjugated with galactosamine and second enhanced permeability nanoparticle of the block copolymer, endothelial cell-specific promoter, and (herpes-simplex-virus)-(thymidine kinase) gene constructed plasmid |
| 06/01/2006 | US20060115498 DNA encoding an antigenic protein of Eimeria apical membrane antigen 1 and use thereof |
| 06/01/2006 | US20060115496 Toxoplasma gondii proteins, nucleic acid molecules, and uses thereof |
| 06/01/2006 | US20060115490 vaccines, immunogenic compositions; diagnostics, enzymatic studies and targets for antibiotics; for treating Staphylococcus aureus infection |